These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1283333)

  • 1. Novel cell junctions induced by activating Thy-1-specific antibodies.
    Millrain MM; Hederer R; Griffiths S; Fryer P; Tomonari K; Robinson PJ
    Int Immunol; 1992 Oct; 4(10):1137-43. PubMed ID: 1283333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Thy-1 on rat T cells and its relevance as a maturation marker of T cells in rats.
    Hozumi K; Masuko T; Hashimoto Y
    Immunol Lett; 1994 Feb; 39(2):179-85. PubMed ID: 7912224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Thy-1-induced proliferation of immature thymocytes expressing the CD3-associated gamma/delta heterodimer.
    MacDonald HR; Miescher GC; Howe RC
    Eur J Immunol; 1987 Nov; 17(11):1677-80. PubMed ID: 2890530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to nonpolymorphic determinants of the Thy-1 molecule inhibit T cell proliferation.
    Hollander N
    J Immunol; 1985 May; 134(5):2916-21. PubMed ID: 2858507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell activation through Thy-1 is associated with the expression of a surface protein (p100) on a subset of CD4 cells.
    Lehuen A; Beaudoin L; Bernard M; Kearney JF; Bach JF; Monteiro RC
    Int Immunol; 1995 Apr; 7(4):607-16. PubMed ID: 7547688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homotypic aggregation of murine T lymphocytes induced by anti-Thy-1 monoclonal antibodies.
    Isobe K; Nakashima I
    Immunology; 1991 Jun; 73(2):159-64. PubMed ID: 1676986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
    Kummer U; Haunschild J; Reisbach G; Delecluse HJ; Thierfelder S
    Eur J Immunol; 1993 Oct; 23(10):2649-54. PubMed ID: 8104797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody.
    Haeryfar SM; Conrad DM; Musgrave B; Hoskin DW
    Immunol Cell Biol; 2005 Aug; 83(4):352-63. PubMed ID: 16033530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A; Goldmacher V; Reiser H; Rock KL
    J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat monoclonal antibodies against three different epitopes of the canine Thy-1 and their depletion capacity in vivo.
    Voss C; Kremmer E; Schumm M; Günther W; Hoffmann-Fezer G; Kolb HJ; Thierfelder S
    Tissue Antigens; 1994 Mar; 43(3):193-7. PubMed ID: 7522358
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens.
    Jones B
    Eur J Immunol; 1983 Aug; 13(8):678-84. PubMed ID: 6193001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Thy-1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy-1 epitopes.
    Pont S; Regnier-Vigouroux A; Naquet P; Blanc D; Pierres A; Marchetto S; Pierres M
    Eur J Immunol; 1985 Dec; 15(12):1222-8. PubMed ID: 2417861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell hybrids that express a VH idiotope-related determinant on a glycoprotein distinct from H-2, Thy-1, and Lyt-1 molecules.
    Chanh TC; Cooper MD
    J Exp Med; 1983 Aug; 158(2):452-64. PubMed ID: 6193222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
    Yang SY; Chouaib S; Dupont B
    J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism.
    Hueber AO; Raposo G; Pierres M; He HT
    J Exp Med; 1994 Mar; 179(3):785-96. PubMed ID: 7906706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.